본문 바로가기
KERD
논문KCI 등재

Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류치의학

초록

Objectives: This study sought to evaluate the efficacy of injecting botulinum toxin into the masseter and temporal muscles in patients with temporomandibular myofascial pain and sleep bruxism. Materials and Methods: The study was conducted based on a clinical record review of 44 patients (36 females and eight males; mean age, 35.70±12.66 years). Patients who underwent the injection of botulinum toxin into the masseter and temporal muscles for the management of temporomandibular myofascial pain and sleep bruxism were included in the study. Patients were diagnosed based on the Diagnostic Criteria for Temporomandibular Disorders. Sleep bruxism was diagnosed according to the criteria defined by the American Academy of Sleep Medicine. The values of the visual analogue scale (VAS) and range of jaw motion, including unassisted maximum mouth opening (MMO), protrusion, and right and left laterotrusion, were observed preoperatively and postoperatively at one-, three-, and six-month follow-up visits. Results: MMO, movements of the right and the left laterotrusion, and protrusion increased significantly (P<0.05), while VAS ratings decreased significantly at the three follow-up points relative to baseline values (P<0.05). Conclusion: Botulinum toxin is an effective treatment for patients with temporomandibular myofascial pain and sleep bruxism.

Abstract

Objectives: This study sought to evaluate the efficacy of injecting botulinum toxin into the masseter and temporal muscles in patients with temporomandibular myofascial pain and sleep bruxism. Materials and Methods: The study was conducted based on a clinical record review of 44 patients (36 females and eight males; mean age, 35.70±12.66 years). Patients who underwent the injection of botulinum toxin into the masseter and temporal muscles for the management of temporomandibular myofascial pain and sleep bruxism were included in the study. Patients were diagnosed based on the Diagnostic Criteria for Temporomandibular Disorders. Sleep bruxism was diagnosed according to the criteria defined by the American Academy of Sleep Medicine. The values of the visual analogue scale (VAS) and range of jaw motion, including unassisted maximum mouth opening (MMO), protrusion, and right and left laterotrusion, were observed preoperatively and postoperatively at one-, three-, and six-month follow-up visits. Results: MMO, movements of the right and the left laterotrusion, and protrusion increased significantly (P<0.05), while VAS ratings decreased significantly at the three follow-up points relative to baseline values (P<0.05). Conclusion: Botulinum toxin is an effective treatment for patients with temporomandibular myofascial pain and sleep bruxism.

참고문헌 (45)

  1. Lora VR, "Prevalence of temporomandibular disorders in postmenopausal women and relationship with pain and HRT", Braz Oral Res, 30, pp.e100~ (2016)[DOI]
  2. Nayyar P, "Botox: broadening the horizon of dentistry", J Clin Diagn Res, 8, pp.ZE25~ZE29 (2014)[DOI]
  3. Miloro M, "Peterson's principles of oral and maxillofacial surgery" (2012), People's Medical Publishing House
  4. "Temporomandibular joint syndrome"[URL]
  5. Koyano K, "Assessment of bruxism in the clinic", J Oral Rehabil, 35, pp.495~508 (2008)[DOI]
  6. Jiménez-Silva A, "Sleep and awake bruxism in adults and its relationship with temporomandibular disorders : a systematic review from 2003 to 2014", Acta Odontol Scand, 75, pp.36~58 (2017)[DOI]
  7. Macfarlane TV, "Factors associated with the temporomandibular disorder, pain dysfunction syndrome(PDS) : Manchester case-control study", Oral Dis, 7, pp.321~330 (2001)[DOI]
  8. Glaros AG, "Parafunctional clenching, pain, and effort in temporomandibular disorders", J Behav Med, 27, pp.91~100 (2004)[DOI]
  9. van der Meulen MJ, "Self-reported oral parafunctions and pain intensity in temporomandibular disorder patients", J Orofac Pain, 20, pp.31~35 (2006)
  10. Magnusson T, "A prospective investigation over two decades on signs and symptoms of temporomandibular disorders and associated variables. A final summary", Acta Odontol Scand, 63, pp.99~109 (2005)[DOI]
  11. Ciancaglini R, "The relationship of bruxism with craniofacial pain and symptoms from the masticatory system in the adult population", J Oral Rehabil, 28, pp.842~848 (2001)[DOI]
  12. Uchida M, "Relations among TMD, bruxism, lifestyle, and psychological stress", Prosthodont Res Pract, 7, pp.171~173 (2008)
  13. Lobbezoo F, "International consensus on the assessment of bruxism : report of a work in progress", J Oral Rehabil, 45, pp.837~844 (2018)[DOI]
  14. Manfredini D, "Epidemiology of bruxism in adults : a systematic review of the literature", J Orofac Pain, 27, pp.99~110 (2013)[DOI]
  15. Maluly M, "Polysomnographic study of the prevalence of sleep bruxism in a population sample", J Dent Res, 92(7Suppl), pp.97S~103S (2013)[DOI]
  16. Ohayon MM, "Risk factors for sleep bruxism in the general population", Chest, 119, pp.53~61 (2001)[DOI]
  17. International classification of sleep disorders, "American Academy of Sleep Medicine", American Academy of Sleep Medicine, 303~311 (2014)
  18. Suvinen TI, "Temporomandibular disorder subtypes according to self-reported physical and psychosocial variables in female patients : a reevaluation", J Oral Rehabil, 32, pp.166~173 (2005)[DOI]
  19. List T, "Management of TMD : evidence from systematic reviews and meta-analyses", J Oral Rehabil, 37, pp.430~451 (2010)[DOI]
  20. Freund B, "The use of botulinum toxin for the treatment of temporomandibular disorders : preliminary findings", J Oral Maxillofac Surg, 57, pp.916~920 (1999)[DOI]
  21. Lee KM, "Botulinum toxin type A injection for the management of myofascial temporomandibular pain disorder", Asian J Oral Maxillofac Surg, 17, pp.100~103 (2005)[DOI]
  22. De la Torre Canales G, "Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review", Clin Oral Investig, 21, pp.727~734 (2017)[DOI]
  23. Schiffman E, "Diagnostic criteria for temporomandibular disorders (DC", TMD)for clinical and research applications: recommendations of the International RDC, J Oral Facial Pain Headache, pp.2014, 28[DOI]
  24. Nitzan DW, "Intraarticular pressure in the functioning human temporomandibular joint and its alteration by uniform elevation of the occlusal plane", J Oral Maxillofac Surg, 52, pp.671~679 (1994)[DOI]
  25. Sharav Y, "Orofacial pain & headache", pp.161~ (2008), Mosby
  26. Güleç M, "Bruksizmin tanı ve tedavisinde güncel yaklaşımlar", Selcuk Dent J, 6, pp.221~228 (2019)
  27. Tinastepe N, "Botulinum toxin for the treatment of bruxism", Cranio, 33, pp.291~298 (2015)[DOI]
  28. Manfredini D, "Relationship between bruxism and temporomandibular disorders : a systematic review of literature from 1998 to 2008", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109, pp.e26~50 (2010)[DOI]
  29. Ariji Y, "Ultrasonographic features of the masseter muscle in female patients with temporomandibular disorder associated with myofascial pain", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 98, pp.337~341 (2004)[DOI]
  30. Amira Mokhtar Abouelhuda, "Non-invasive different modalities of treatment for temporomandibular disorders: review of literature", 대한구강악안면외과학회지, 44(2), pp.43~51 (2018), 대한구강악안면외과학회
  31. Fernández-Núñez T, "Efficacy of botulinum toxin in the treatment of bruxism: systematic review", Med Oral Patol Oral Cir Bucal, 24, pp.e416~e424 (2019)[DOI]
  32. Al-Wayli H, "Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study", J Clin Exp Dent, 9, pp.e112~e117 (2017)[DOI]
  33. Sidebottom AJ, "Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study", Br J Oral Maxillofac Surg, 51, pp.199~205 (2013)[DOI]
  34. Ahn J, "Botulinum toxin for masseter reduction in Asian patients", Arch Facial Plast Surg, 6, pp.188~191 (2004)[DOI]
  35. Majid OW, "Clinical use of botulinum toxins in oral and maxillofacial surgery", Int J Oral Maxillofac Surg, 39, pp.197~207 (2010)[DOI]
  36. Dressler D, "Botulinum toxin: mechanisms of action", Arq Neuropsiquiatr, 63, pp.180~185 (2005)[DOI]
  37. Lee SJ, "Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial", Am J Phys Med Rehabil, 89, pp.16~23 (2010)[DOI]
  38. Guarda-Nardini L, "Efficacy of botulinum toxin in treating myofascial pain in bruxers : a controlled placebo pilot study", Cranio, 26, pp.126~135 (2008)[DOI]
  39. Guarda-Nardini L, "Myofascial pain of the jaw muscles : comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique", Cranio, 30, pp.95~102 (2012)[DOI]
  40. Ernberg M, "Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain : a randomized, controlled, double-blind multicenter study", Pain, 152, pp.1988~1996 (2011)[DOI]
  41. 김현석, "A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment", Maxillofacial Plastic Reconstructive Surgery, 38(1), pp.1~5 (2016), 대한악안면성형재건외과학회[DOI]
  42. Kurtoglu C, "Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement", J Oral Maxillofac Surg, 66, pp.1644~1651 (2008)[DOI]
  43. Klein FH, "Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy", An Bras Dermatol, 89, pp.878~884 (2014)[DOI]
  44. Borodic G, "Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications", Facial Plast Surg Clin North Am, 15, pp.11~16 (2007)[DOI]
  45. Chen YW, "Botulinum toxin therapy for temporomandibular joint disorders : a systematic review of randomized controlled trials", Int J Oral Maxillofac Surg, 44, pp.1018~1026 (2015)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (12건)